News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Chinese Orthopedic Implant Maker China Kanghui IPO Prices in Midpoint, Raises $68.4 Million
August 11, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Wall Street Journal -- Medical-device maker China Kanghui Holdings' initial public offering of at least 6.7 million American depositary shares priced at $10.25 Tuesday, in the middle of the expected price range of $9.25 to $11.25.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Mergers & acquisitions
BioMarin Expands Enzyme Expertise With $270M Inozyme Buy
May 16, 2025
·
2 min read
·
Tristan Manalac
Deals
Bluebird’s Private Equity Buyout Boosts Upfront Cash for Shareholders
May 15, 2025
·
1 min read
Obesity
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
May 14, 2025
·
2 min read
·
Dan Samorodnitsky
Drug discovery
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal
May 14, 2025
·
2 min read
·
Annalee Armstrong